Statin-mediated inhibition of RAS prenylation activates ER stress to enhance the immunogenicity of KRAS mutant cancer.
Nam GH, Kwon M, Jung H, Ko E, Kim SA, Choi Y, Song SJ, Kim S, Lee Y, Kim GB, Han J, Woo J, Cho Y, Jeong C, Park SY, Roberts TM, Cho YB, Kim IS.
Nam GH, et al. Among authors: jeong c.
J Immunother Cancer. 2021 Jul;9(7):e002474. doi: 10.1136/jitc-2021-002474.
J Immunother Cancer. 2021.
PMID: 34330763
Free PMC article.